SHP656, a polysialylated recombinant factor VIII (PSA‐rFVIII): First‐in‐human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A

por Tiede, Andreas, Allen, Geoffrey, Bauer, Alexander, Chowdary, Pratima, Collins, Peter, Goldstein, Brahm, Jiang, Hongyu Jeanne, Kӧck, Kathleen, Takács, István, Timofeeva, Margarita, Wolfsegger, Martin, Srivastava, Shouryadeep
Publicado 2019